Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARRY-438162 in Rheumatoid Arthritis
NCT00650767Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 2, randomised, double-blind trial of binimetinib in rheumatoid arthritis (RA) (4 arms), sponsored by Pfizer. Primary endpoint: American College of Rheumatology 20% Response Rate at 12 weeks. Started Mar 2008; status: completed.
02
Drugs
binimetinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00650767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00650767.